Treosulfan
- Generic Name
- Treosulfan
- Brand Names
- Trecondi
- Drug Type
- Small Molecule
- Chemical Formula
- C6H14O8S2
- CAS Number
- 299-75-2
- Unique Ingredient Identifier
- CO61ER3EPI
- Background
Treosulfan is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Treosulfan has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
- Indication
Not Available
- Associated Conditions
- -
- Associated Therapies
- HSCT conditioning therapy
MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Phase 2
- Conditions
- First Posted Date
- 2005-08-11
- Last Posted Date
- 2007-10-04
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 30
- Registration Number
- NCT00129155
- Locations
- 🇫🇷
Hôpital Edouard Herriot, Lyon, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath